- Report
- August 2025
- 150 Pages
Global
From €5135EUR$5,950USD£4,463GBP
- Report
- July 2025
- 110 Pages
Global
From €5135EUR$5,950USD£4,463GBP
- Report
- November 2025
- 199 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- August 2025
- 195 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- August 2025
- 189 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- August 2025
- 194 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- August 2025
- 186 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- August 2025
- 191 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- August 2025
- 192 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- August 2025
- 195 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- October 2025
Global
From €4229EUR$4,900USD£3,676GBP
From €4229EUR$4,900USD£3,676GBP
- Report
- January 2026
- 452 Pages
Global
From €5049EUR$5,850USD£4,388GBP
- Report
- January 2026
- 276 Pages
Global
From €5049EUR$5,850USD£4,388GBP
- Report
- January 2026
- 150 Pages
Global
From €5049EUR$5,850USD£4,388GBP
- Report
- January 2026
- 282 Pages
Global
From €5049EUR$5,850USD£4,388GBP
- Report
- September 2025
- 250 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- September 2025
- 250 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- September 2025
- 250 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- September 2025
- 250 Pages
Global
From €3875EUR$4,490USD£3,368GBP

The Arthritis Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Arthritis drugs are used to treat the inflammation and pain associated with arthritis, a condition that affects the joints and surrounding tissues. These drugs can be divided into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). NSAIDs are used to reduce inflammation and pain, while DMARDs are used to slow the progression of the disease.
The Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, AbbVie, Johnson & Johnson, and Novartis. Show Less Read more